AbbVie traded at $152.34 this Friday June 24th, increasing $2.89 or 1.93 percent since the previous trading session. Looking back, over the last four weeks, AbbVie gained 0.25 percent. Over the last 12 months, its price rose by 34.84 percent. Looking ahead, we forecast AbbVie to be priced at 148.24 by the end of this quarter and at 136.60 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
152.34
Daily Change
1.93%
Yearly
34.84%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Eisai 5,561.00 77.00 1.40% -52.73%
AbbVie 152.34 2.89 1.93% 34.84%
Abbott 109.45 3.24 3.05% -2.90%
ALKERMES 29.71 0.15 0.51% 23.12%
Amgen 245.37 2.28 0.94% 1.11%
AstraZeneca 10,776.00 396.00 3.82% 26.79%
Astrazeneca 66.90 2.45 3.80% 12.72%
Biogen 211.93 0.55 0.26% -39.09%
BioMarin Pharmaceutical 86.85 2.30 2.72% 2.43%
Bristol-Myers Squibb 78.96 1.27 1.63% 18.31%
ChemoCentryx 26.15 -1.36 -4.94% 89.91%
Coherus Biosciences 7.50 0.11 1.49% -51.33%
Endo International 0.37 -0.02 -5.72% -92.53%
Gilead Sciences 63.08 0.50 0.80% -7.07%
GlaxoSmithKline 1,756.20 36.60 2.13% 24.27%
Horizon Pharma 85.13 2.22 2.68% -11.25%
Intercept Pharmaceuticals 13.56 0.03 0.22% -38.53%
Infinity Pharmaceuticals 0.73 -0.10 -11.89% -75.59%
Jazz Pharmaceuticals 153.49 2.72 1.80% -15.24%
J&J 182.29 2.63 1.46% 11.01%
Eli Lilly 325.62 12.90 4.13% 41.44%
Medtronic 90.22 1.55 1.75% -27.78%
Merck & Co 93.13 1.13 1.23% 20.63%
Neurocrine Biosciences 98.24 0.84 0.86% -2.04%
Novartis 80.60 2.37 3.03% -4.80%
Pacira 57.43 1.15 2.04% -9.59%
Pfizer 51.59 1.50 2.99% 32.35%
Perrigo 41.21 0.90 2.23% -12.09%
Ultragenyx Pharmaceutical 60.57 0.58 0.97% -35.45%
Regeneron Pharmaceuticals 612.49 5.10 0.84% 11.25%
Roche Holding 318.80 12.50 4.08% -7.54%
Revance Therapeutics 15.28 0.15 0.99% -50.42%
Sanofi 100.56 4.81 5.02% 13.95%
Teva Pharmaceutical Industries 7.74 0.07 0.91% -25.29%
UCB 80.94 -0.74 -0.91% -6.71%
United Therapeutics 238.95 -1.91 -0.79% 32.75%
Vertex Pharmaceuticals 292.55 9.05 3.19% 50.54%
Zoetis 174.61 5.44 3.22% -6.74%

Indexes Price Day Year
US500 3912 116.01 3.06% -8.62%

AbbVie
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.